Document:

Exhibit 10.9

 

FIRST AMENDMENT TO CAPITAL STOCK PURCHASE
WARRANTS

 

This
First Amendment to capital Stock Purchase Warrants (this “Amendment”) is made effective as
of this 18th day of June, 2017, by and between NeuroOne, Inc.,
a Delaware corporation (the “Company”), and each of those persons and entities, severally and
not jointly, who are holders of the Company’s Capital Stock Purchase Warrants (each, a “Holder”
and collectively, the “Holders”).

 

Background

 

The Company and the
Holders entered into Subscription Agreements originally dated as of November 21, 2016 (the “Subscription Agreements”).
Pursuant to the terms and conditions of the Subscription Agreements, the Company issued to the Holders convertible promissory notes
and Capital Stock Purchase Warrants (the “Warrants”).

 

Pursuant to the consent
of the holders of a majority in original aggregate principal amount of the Related Notes pursuant to Section 9(h) of the Warrants,
the Warrants are hereby amended as follows:

 

Terms
and Conditions

 

1.          Amendment
to Preamble of the Warrants. The first paragraph of the preamble of the Warrants is hereby deleted in its entirety and
replaced with the following:

 

“This
Certified That, for value received, [NAME OF HOLDER] (the “Holder”) is entitled to subscribe
for and purchase from NeuroOne, Inc.,
a Delaware corporation (the “Company”), at any time commencing on the date the Note converts pursuant
to Section 3.1 of the Note and expiring on November 21, 2021 (the “Warrant Exercise Term”), the Shares
at the Exercise Price (each as defined in Section 1 below).”

 

2.          Amendment
to Section 1 of the Warrants.  Section 1 of the Warrants is hereby
deleted in its entirety and replaced with the following:

 

“1.          Shares.
The Holder has, subject to the terms set forth herein, the right to purchase, at any time during the Warrant Exercise Term, up
to that number of Conversion Shares equal to the number of Conversion Shares received by the Holder upon conversion of the Note,
at a per share exercise price equal to the price at which the Note so converted (the “Exercise Price”).
The Exercise Price is subject to adjustment as provided in Section 3 hereof. Shares of the Company’s common stock,
par value $0.0001 (the “Common Stock”) and the Conversion Shares are referred to herein collectively,
and without distinction, as the “Shares”.”

 

3.          Notice
to Transferees. Pursuant to Section 9(h) of the Warrants, this Amendment shall be binding on all holders of the Warrants,
even if they do not execute such consent, amendment or waiver. The terms of this Amendment shall be binding upon and shall inure
to the benefit of any successors or permitted assigns of the Company and the Holders and of the Shares issued or issuable upon
the exercise of the Warrants. Any successor, permitted assign or transferee of the Warrant after the date hereof shall be deemed
to have acquired the Warrant as amended by this Amendment.

 

    	 	1	 

     

    

 

4.          Construction.
Unless otherwise defined herein, capitalized terms shall have the meanings set forth in the Subscription Agreements and the Warrants,
as the case may be. The terms of this Amendment amend and modify the Subscription Agreements and the Warrants as if fully set forth
in the Subscription Agreements and the Warrants. If there is any conflict between the terms, conditions and obligations of this
Amendment and the Subscription Agreements or the Warrants, this Amendment’s terms, conditions and obligations shall control.
All other provisions of the Subscription Agreements and the Warrants not specifically modified by this Amendment are preserved.

 

signatures
on the following page

 

    	 	2	 

     

    

 

In
Witness Whereof, this First Amendment to Capital Stock Purchase Warrants is made effective as of the date first set
forth above.

 

	THE COMPANY:	 
	 	 
	NeuroOne, Inc.	 
	 	 	 
	By: 	/s/ David A. Rosa	 
	Name:   David A. Rosa	 
	Title:     Chief Executive Officer	 

 

    Signature
                                         Page to First Amendment to Capital Stock Purchase Warrants of
 Neuroone, Inc.Exhibit 10.10

 

 

 

Stockholders
Agreement

 

of

 

NeuroOne,
Inc.

 

 

 

Dated Effective as of October 20, 2016

 

 

 

 

 

     

     

    

 

TABLE OF CONTENTS

 

	 	 	Page
	 	 	 
	1.	GENERAL	1
	 	 	 
	 	1.1	Definitions	1
	 	 	 
	2.	RESTRICTIONS ON TRANSFER	3
	 	 	 
	 	2.1	General Restrictions on Transfer	3
	 	2.2	Notice of Transfer	4
	 	2.3	Exempt Transfers	4
	 	2.4	Existing Rights	4
	 	2.5	Legend	4
	 	 	 
	3.	PRE-EMPTIVE RIGHT	5
	 	 	 
	 	3.1	Subsequent Offerings	5
	 	3.2	Exercise of Rights	5
	 	3.3	Issuance of Equity Securities to Other Persons	6
	 	3.4	Termination of Pre-Emptive Right	6
	 	3.5	Excluded Securities	6
	 	 	 
	4.	VOTING	7
	 	 	 
	 	4.1	General	7
	 	4.2	Manner of Voting	7
	 	4.3	Board Size	7
	 	4.4	Election of Directors	7
	 	4.5	Failure to Designate a Director	7
	 	4.6	No Liability for Election of Designated Director	8
	 	4.7	Drag-Along Right	8
	 	4.8	Irrevocable Proxy	10
	 	4.9	Additional Shares	11
	 	 	 
	5.	MISCELLANEOUS	11
	 	 	 
	 	5.1	Ownership	11
	 	5.2	Further Action	11
	 	5.3	Specific Performance	11
	 	5.4	Remedies Cumulative	11
	 	5.5	Termination	11
	 	5.6	Governing Law; Venue; Waiver of Jury Trial	12
	 	5.7	Successors and Assigns	12
	 	5.8	Transfers	12
	 	5.9	Entire Agreement	12
	 	5.10	Severability	13

 

    	i

     

    

 

	 	5.11	Amendment and Waiver	13
	 	5.12	Delays or Omissions	13
	 	5.13	Notices	14
	 	5.14	Attorneys’ Fees	14
	 	5.15	Titles and Subtitles	14
	 	5.16	Additional Major Stockholders	14
	 	5.17	Aggregation of Stock	14
	 	5.18	Counterparts	14
	 	 	 
	Schedule A - LIST OF STOCKHOLDERS	A-1
	Exhibit 1 - ADOPTION AGREEMENT	1-1

 

    	ii

     

    

 

NEUROONE,
INC.

 

stockholders
AGREEMENT

 

This
Stockholders Agreement (the “Agreement”)
is entered into effective as of October 20, 2016 (the “Effective Date”) by and among NeuroOne,
Inc., a Delaware corporation (the “Company”), and the holders of the Company’s common stock
as listed on Schedule A attached hereto (each, a “Stockholder”
and collectively, the “Stockholders”).

 

Recitals

 

WHEREAS, the Stockholders
are the owners of the outstanding capital stock of the Company; and

 

WHEREAS, the parties
wish to agree to certain rights and obligations regarding the capital stock of the Company, including without limitation, restrictions
on transfer and buy-sell provisions.

 

NOW, THEREFORE, in
consideration of the mutual covenants contained herein, the receipt and sufficiency of which are hereby acknowledged, the parties
agree as follows:

 

Agreement

 

1.             GENERAL.

 

1.1          Definitions.
Capitalized terms not otherwise
defined in this Agreement, shall have the following meanings:

 

(a)          “Affiliate”
means, with respect to any specified Person, any other Person who or which, directly or indirectly, controls, is controlled by,
or is under common control with such specified Person, including without limitation any partner, officer, director, manager or
employee of such Person and any venture capital fund now or hereafter existing that is controlled by or under common control with
one or more general partners or managing members of, or shares the same management company with, such Person.

 

(b)          “Board”
means the Board of Directors of the Company.

 

(c)          “Certificate”
means the Company’s certificate of incorporation, as amended or restated from time to time as permitted hereby.

 

(d)          “Change
in Control” means (i) the sale of substantially all of the assets of the Company, or (ii) the consolidation or merger
of the Company with or into any other corporation or other entity or person or any other corporate reorganization, in which the
capital stock of the Company prior to such consolidation, merger or reorganization, represents less than fifty percent (50%) of
the voting power of the surviving entity immediately after such consolidation, merger or reorganization; provided, however, that
(A) any consolidation or merger effected exclusively to change the domicile of the Company, (B) any transaction or series of transactions
principally for bona fide equity financing purposes in which cash is received by the Company or indebtedness of the Company is
cancelled or converted or a combination thereof, or (C) a sale, lease, transfer, exclusive license or other disposition to, or
merger with or into, a wholly owned subsidiary of the Company shall not constitute a Change in Control.

 

    	 	1	 

     

    

 

(e)          
“Common Stock” means the Company’s common stock, par value $0.0001 per share.

 

(f)          “Equity
Securities” means (i) any Common Stock, Preferred Stock or other security of the Company, (ii) any security
convertible, with or without consideration, into any Common Stock, Preferred Stock or other security (including any option to purchase
such a convertible security), (iii) any security carrying any warrant or right to subscribe to or purchase any Common Stock,
Preferred Stock or other security or (iv) any such warrant or right.

 

(g)          “Initial
Offering” means the Company’s first firm commitment underwritten public offering of its Common Stock registered
under the Securities Act or merger transaction between the Company and a company that is subject to the reporting requirements
of the Securities Exchange Act of 1934, as amended.

 

(h)          “Major
Stockholder” means any holder of Shares who or which, together with any of such holder’s Affiliates, holds
five percent (5%) or more of the outstanding Shares, or any assignee of record of such Shares in accordance with Section 2.

 

(i)          “Person”
means any individual, corporation, partnership, trust, limited liability company,
association or other
entity.

 

(j)          “Preferred
Stock” means any class or series of preferred stock issued by the Company that rights and/or preferences in addition
and/or superior to the Common Stock that is hereafter acquired by any of the Stockholders and their permitted assigns, taken together.

 

(k)          “Pro
Rata Share” means, as to each Major Stockholder, the fraction determined by dividing (a) the sum of (i) the
number of shares of the Company’s outstanding Shares (treating all shares of convertible Preferred Stock or Warrants to acquire
convertible Preferred Stock on an as-converted to Common Stock basis and including all shares of Common Stock issuable upon the
exercise of outstanding Warrants or options) which such Major Stockholder holds of record as of the determination of such Major
Stockholder’s Pro Rata Share, by (b) the total number of shares of the Company’s outstanding Shares (treating
all shares of convertible Preferred Stock or warrants to acquire convertible Preferred Stock on an as-converted to Common Stock
basis and including all shares of Common Stock issuable upon the exercise of outstanding Warrants or options) as of as of the determination
of such Major Stockholder’s Pro Rata Share.

 

(l)          “Rule
144” means Rule 144, as promulgated under the Securities Act, or any similar or analogous rule promulgated under
the Securities Act.

 

(m)          “Securities
Act” means the Securities Act of 1933, as amended.

 

    	 	2	 

     

    

 

(n)           “Shares”
means all shares of capital stock of the Company (including, without limitation, all shares of the Common Stock held or
issuable upon conversion of convertible Preferred Stock) registered in the name of a Stockholder or beneficially owned by such
Stockholder as of the Effective Date hereof and any and all other securities of the Company legally or beneficially acquired by
each of the Stockholders after the Effective Date.

 

(o)           “Subsidiary”
means, with respect to any entity, any entity of which securities or other ownership interests having ordinary voting power to
elect a majority of the board of directors or other persons performing similar functions are owned directly or indirectly by such
entity or any Subsidiary of such entity or by such entity and one or more Subsidiaries of such entity.

 

(p)           “Transfer”
means any sale, assignment, encumbrance, hypothecation, pledge, conveyance in trust, gift, transfer by request, devise or descent,
or other transfer or disposition of any kind, including, but not limited to, transfers to receivers, levying creditors, trustees
or receivers in bankruptcy proceedings or general assignees for the benefit of creditors, whether voluntary or by operation of
law, directly or indirectly, of any of the Shares of any Stockholder.

 

(q)           “Warrants”
means warrants to purchase Common Stock and Preferred Stock held by Major Stockholders.

 

2.             RESTRICTIONS
ON TRANSFER.

 

2.1          General
Restrictions on Transfer.

 

(a)           Each
party hereto agrees not to make any disposition of all or any portion of the Shares unless and until:

 

(i)          There
is then in effect a registration statement under the Securities Act covering such proposed disposition and such disposition is
made in accordance with such registration statement; or

 

(ii)         (A) The
transferee has agreed in writing to be bound by the terms of this Agreement, (B) such party shall have notified the Company
of the proposed disposition and shall have furnished the Company with a detailed statement of the circumstances surrounding the
proposed disposition, and (C) if reasonably requested by the Company, such party shall have furnished the Company with an
opinion of counsel, reasonably satisfactory to the Company, that such disposition will not require registration of such shares
under the Securities Act and applicable state and foreign securities law. Notwithstanding the foregoing, no such opinion of counsel
shall be required in connection with any transfer of Shares made in compliance with Rule 144.

 

Notwithstanding the provisions
of clauses (i) and (ii) above, no such registration statement or opinion of counsel shall be necessary for a transfer by a party
hereto that is: (A) a partnership transferring to its partners or former partners in accordance with partnership interests
or to an Affiliate of such partnership; (B) a corporation transferring to a wholly-owned subsidiary or a parent corporation
that owns all of the capital stock of such corporation; (C) a limited liability company transferring to its members or former
members in accordance with their interest in the limited liability company; (D) an individual transferring to such individual’s
family member or trust for the benefit of such individual; and (E) transfer to any Affiliate of a party; provided, however, that
in each case the transferee will be subject to the terms of this Agreement to the same extent as if he were an original party hereto.

 

    	 	3	 

     

    

 

2.2          Notice
of Transfer. Subject
to compliance with the foregoing Section 2.1, if a Major Stockholder proposes to Transfer any Shares (each a “Selling
Stockholder”), the Selling
Stockholder shall promptly give written notice (each a “Transfer
Notice”) simultaneously to
the Company and to each of the other Major Stockholders at least thirty (30) days prior to the closing of such Transfer. The Transfer
Notice shall describe in reasonable detail the proposed Transfer including, without limitation, the number and type of Shares
of the Selling Stockholder to be transferred (the “Transfer
Shares”), the nature of such
Transfer, the consideration to be paid, and the name and address of each prospective purchaser or transferee. In
the event that the Transfer is being made pursuant to the provisions of Section 2.3,
the Transfer Notice shall also state under which clause of such Section 2.3 the Selling Stockholder proposes to make such
Transfer.

 

2.3          Exempt
Transfers. Notwithstanding the foregoing, the provisions of Section 2
shall not apply to: (a) the sale of any Shares to the public pursuant to a registration statement filed with, and declared
effective by, the Securities and Exchange Commission under the Securities Act; (b) any Transfer with respect to which the Board
waives the application of the provisions of this Section 2; or (c) any Transfer (i) that is a conveyance in trust, gift
or devise or descent of any Shares by a Stockholder to any family member, without consideration and for estate planning purposes,
so long as the transferee agrees in writing to be bound by this Agreement as though an original Stockholder party hereto, (ii)
to any person occurring as a matter of law upon the death, divorce or declaration of incompetence of a Stockholder, so long as
the transferee agrees in writing to be bound by this Agreement as though an original Stockholder party hereto, (iii) to a receiver,
levying creditor, trustee or receiver in bankruptcy proceedings or to a general assignee for the benefit of creditors, whether
voluntary or by operation of law, so long as the transferee agrees in writing to be bound by this Agreement as though an original
Stockholder party hereto, (iv) to the Company, (v) by merger or share exchange or an exchange of existing shares for other shares
of the same or a different class or series in the Company, or (vi) to any equity owner (partner, stockholder, member or the like)
of any Stockholder that is an “accredited
investor”, as that term is defined in Rule 501
of Regulation D, as promulgated under the Securities Act,
so long as the transferee agrees in writing to be bound by this Agreement as though an original Stockholder party hereto.

 

2.4          Existing
Rights. This Agreement is subject
to, and shall in no manner limit the right which the Company may have to repurchase securities from the Stockholder pursuant to
(a) a
stock restriction agreement or other agreement between the Company and the Stockholder, and (b) any
right of first refusal set forth in the bylaws of the Company or in any incentive stock option, restricted stock or other incentive
plan or agreement adopted by the Company for the benefit of its employees, non-employee directors, contractors and consultants.

 

2.5          Legend.

 

(a)          Each
certificate representing Shares shall (unless otherwise permitted by the provisions of the Agreement) be stamped or otherwise imprinted
with a legend substantially similar to the following (in addition to any legend required under applicable state securities laws)
(the “Legend”):

 

    	 	4	 

     

    

 

THE SECURITIES REPRESENTED HEREBY HAVE
NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 (THE “ACT”) AND MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED,
PLEDGED OR HYPOTHECATED UNLESS AND UNTIL REGISTERED UNDER THE ACT OR, IN THE OPINION OF COUNSEL SATISFACTORY TO THE ISSUER OF THESE
SECURITIES, SUCH OFFER, SALE OR TRANSFER, PLEDGE OR HYPOTHECATION IS IN COMPLIANCE THEREWITH.

 

THE SHARES REPRESENTED BY THIS CERTIFICATE
ARE SUBJECT TO A RIGHT OF FIRST REFUSAL OPTION IN FAVOR OF THE CORPORATION AND/OR ITS ASSIGNEE(S), AS PROVIDED IN THE BYLAWS OF
THE CORPORATION.

 

THE SALE, PLEDGE, HYPOTHECATION OR
TRANSFER OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE IS SUBJECT TO THE TERMS AND CONDITIONS OF A STOCKHOLDERS AGREEMENT AMONG
THE CORPORATION AND ITS STOCKHOLDERS. COPIES OF SUCH AGREEMENT MAY BE OBTAINED UPON WRITTEN REQUEST TO THE SECRETARY OF THE CORPORATION.

 

(b)           During
the term of this Agreement, the Company shall not remove, and shall not permit to be removed (upon registration of transfer, re-issuance
of otherwise), the Legend from any such certificate and shall place or cause to be placed such legend on any new certificate issued
to represent Shares theretofore represented by a certificate bearing such legend. The Stockholders agree that the Company shall
instruct its transfer agent to impose transfer restrictions on the shares represented by certificates bearing the Legend to enforce
the provisions of this Agreement and the Company agrees to promptly do so.

 

(c)           In
the event of any issuance of Shares after the Effective Date to any of the Stockholders (including, without limitation, in connection
with any stock split, stock dividend, recapitalization, reorganization, or the like), such Shares shall become subject to this
Agreement and shall be endorsed with the Legend.

 

(d)           The
foregoing legend shall be removed only upon termination of this Agreement.

 

3.             PRE-EMPTIVE
RIGHT.

 

3.1           Subsequent
Offerings. Each Major Stockholder
shall have a right to purchase such Major Stockholder’s
Pro Rata Share of all Equity Securities that the Company may, from time to time, propose to sell and issue after the Effective
Date, other than the Equity Securities excluded by Section 3.5 (the “Pre-Emptive
Right”).

 

3.2           Exercise
of Rights. If the Company proposes
to issue any Equity Securities, it shall give each Major Stockholder written notice of its intention, describing the Equity Securities,
the price and the terms and conditions upon which the Company proposes to issue the same. Each Major Stockholder shall have fifteen
(15) days from the giving of such notice to exercise the Pre-Emptive Right and agree to purchase its Pro Rata Share of such Equity
Securities for the price and upon the terms and conditions specified in the notice by giving written notice to the Company and
stating therein the quantity of Equity Securities to be purchased. Notwithstanding the foregoing, the Company shall not be required
to offer or sell such Equity Securities to any Major Stockholder that would cause the Company to be in violation of applicable
Federal or state securities laws by virtue of such offer or sale.

 

    	 	5	 

     

    

 

3.3           Issuance
of Equity Securities to Other Persons. If
not all of the Major Stockholders elect to purchase their Pro Rata Share of the Equity Securities, then the Company shall promptly
notify in writing the Major Stockholders that have so elected (the “Electing
Stockholders”) and offer the Electing
Stockholders the right to acquire such unsubscribed shares. Each Electing Stockholder shall have five (5) business days after receipt
of such notice to notify the Company of such Electing Stockholder’s
election to purchase all or a portion thereof of the unsubscribed shares. If the Major Stockholders fail to exercise in full the
rights set forth in Section 3.2 and this Section 3.3, the Company shall have ninety (90) days thereafter to sell
the Equity Securities in respect of which the Major Stockholders’
rights were not exercised, at a price and upon terms and conditions no more favorable to the purchasers thereof than specified
in the Company’s original notice of the sale of such Equity
Securities to the Major Stockholders pursuant to Section 3.2.
If the Company has not sold such Equity Securities within ninety (90) days of such notice, the Company shall not thereafter issue
or sell any Equity Securities, without first offering such securities to the Major Stockholders in the manner provided above.

 

3.4           Termination
of Pre-Emptive Right. The Pre-Emptive
Right shall not apply to and shall terminate upon the earlier of (i) the
closing of the Initial Offering, or (ii) upon the occurrence of a Change in Control.

 

3.5           Excluded
Securities. The Pre-Emptive
Right shall not apply to the following Equity Securities:

 

(a)          shares
of Common Stock issued or issuable upon conversion of Preferred Stock or as a dividend or distribution on Shares;

 

(b)          shares
of Common Stock and/or options, warrants or other purchase rights and the shares of Common Stock issued or issuable pursuant to
such options, warrants or other rights issued after the Effective Date to employees, officers or directors of, or consultants or
advisors to, the Company or any subsidiary of the Company pursuant to (x) the NeuroOne, Inc. 2016 Stock Plan as in effect on the
Effective Date (the “Existing Option Plan”), or (y) any amendment to or restatement of the Existing Option
Plan or any new stock purchase or stock option plans or other similar arrangements that are approved by the Board;

 

(c)          shares
of Common Stock issued or issuable pursuant to the exercise of options, warrants or convertible securities outstanding as of the
Effective Date;

 

(d)          shares
of Common Stock or Preferred Stock issued or issuable pursuant to a stock split, combination of shares, reclassification or recapitalization
of the capital stock of the Company;

 

(e)          shares
of Common Stock (or warrants exercisable for Common Stock) or Preferred Stock issued or issuable pursuant to any equipment loan
or leasing arrangement, real property leasing arrangement or debt financing from a bank or similar financial institution approved
by the Board;

 

    	 	6	 

     

    

 

(f)          any
Equity Securities issued or issuable pursuant to the acquisition of another entity by the Company by merger, purchase of substantially
all of the assets or other reorganization that has been approved by the Board;

 

(g)          any
Equity Securities issued or issuable in connection with strategic transactions involving the Company and other entities, including
(i) joint ventures, manufacturing, marketing or distribution arrangements, or (ii) technology license, transfer or development
arrangements; provided, however, that the issuance of shares therein is not principally for equity financing purposes and the transaction
has been approved by the Board; and

 

(h)          any
Equity Securities that are issued by the Company in connection with the Initial Offering.

 

4.            VOTING.

 

4.1           General.
The Stockholders each agree
to hold all their Shares (including, without limitation, all shares of the Common Stock now held or issuable upon conversion of
any convertible Preferred Stock) subject to, and to vote their Shares in accordance with, the provisions of this Section 4.

 

4.2           Manner
of Voting. The voting of shares
pursuant to this Agreement may be effected in person, by proxy, by written consent, or in any other manner permitted by applicable
law. All of the Stockholders agree to execute any written consents required to perform the obligations of this Agreement, and the
Company agrees at the request of any party entitled to designate Directors (as defined below) to call a special meeting of Stockholders
for the purpose of electing Directors as provided herein.

 

4.3           Board
Size. At all regular or special
meetings of the stockholders of the Company following the Effective Date, each of the Stockholders shall vote all of their respective
Shares held by them (or the holders thereof shall consent pursuant to an action by written consent of the holders of capital stock
of the Company) so as to ensure that the size and composition of the Board is as directed by the then current Board (each a “Director”
and, collectively, the “Directors”).
The initial size of the Board shall be two (2) Directors.

 

4.4           Election
of Directors. On all matters
relating to the election of the Directors, the Stockholders agree to vote all Shares held by them (or the holders thereof shall
consent pursuant to an action by written consent of the holders of capital stock of the Company) so as to elect initially the following
Directors Dave A. Rosa and Paul Buchman and thereafter the nominees recommended by the then current Board.

 

4.5           Failure
to Designate a Director.
In the absence of any designation from the Persons or groups with the right to designate a Director as specified above, the Director
previously designated by them and then serving shall be reelected if still eligible to serve as provided herein.

 

    	 	7	 

     

    

 

4.6           No
Liability for Election of Designated Director. No
party, nor any Affiliate of any such party, shall have any liability as a result of nominating or designating a person for election
as a Director for any act or omission by such person in his or her capacity as a Director, nor shall any party have any liability
as a result of voting for any such person in accordance with the provisions of this Agreement. None of the parties hereto and no
officer, director, stockholder, partner, employee or agent of any party makes any representation or warranty as to the fitness
or competence of the nominee of any party hereunder to serve on the Board by virtue of such party’s
execution of this Agreement or by the act of such party in voting for such nominee pursuant to this Agreement.

 

4.7           Drag-Along
Right.

 

(a)           In
the event that the Board votes to approve a Change in Control, then each Stockholder hereby agrees:

 

(i)          if
such Change in Control requires stockholder approval, with respect to all Shares that such Stockholder owns or over which such
Stockholder otherwise exercises voting power, to vote (i) all such Shares in favor of, and adopt, such Change in Control (together
with any related amendment to the Certificate required in order to implement such Change in Control), and (ii) in opposition to
any and all other proposals that could reasonably be expected to delay or impair the ability of the Company to consummate such
Change in Control;

 

(ii)         if
such Change in Control is to be effected by sale of Company capital stock to a third party (a “Stock Sale”),
to sell the same proportion of shares of capital stock of the Company beneficially held by such Stockholder as is being sold by
all other holders of Company capital stock and, except as permitted in Section 4.7(b), on the same terms and conditions
as holders of the same class or series of Company capital stock are so selling;

 

(iii)        to
execute and deliver all related documentation and take such other action in support of the Change in Control as shall reasonably
be requested by the Company in order to carry out the terms and provisions of this Section 4.7, including, without limitation,
executing and delivering instruments of conveyance and transfer, and any purchase agreement, merger agreement, indemnity agreement,
escrow agreement, exchange agreement, consent, waiver, governmental filing, share certificates duly endorsed for transfer (free
and clear of impermissible liens, claims and encumbrances) and any similar or related documents;

 

(iv)        not
to deposit, and to cause their Affiliates not to deposit, except as provided in this Agreement, any Shares owned by such Stockholder
or its Affiliate in a voting trust or subject any Shares to any arrangement or agreement with respect to the voting of such Shares,
unless specifically requested to do so by the acquirer in connection with the Change in Control;

 

(v)         not
to assert or exercise any dissenters’ rights or rights of appraisal under applicable law at any time with respect to such
Change in Control; and

 

    	 	8	 

     

    

 

(vi)        if
the consideration to be paid in exchange for the Shares in any Change in Control includes any securities and due receipt thereof
by any Stockholder would require under applicable law (A) the registration or qualification of such securities or of any person
as a broker or dealer or agent with respect to such securities, or (B) the provision to any Stockholder of any information other
than such information as a prudent issuer would generally furnish in an offering made solely to “accredited investors”
as defined in Regulation D, as promulgated under the Securities Act, the Company may cause to be paid to any such Stockholder in
lieu thereof, against surrender of the Shares which would have otherwise been sold by such Stockholder, an amount in cash equal
to the fair value (as determined in good faith by the Company) of the securities which such Stockholder would otherwise receive
as of the date of the issuance of such securities in exchange for such Stockholder’s Shares.

 

(b)          Notwithstanding
the foregoing Section 4.7(a), no Stockholder will be required to comply with such section in connection with any proposed
Change in Control unless:

 

(i)          any
representations and warranties to be made by such Stockholder in connection with such proposed Change in Control are limited to
representations and warranties related to authority, ownership and the ability to convey title to such Stockholder’s Shares,
including, without limitation, representations and warranties that (A) the Stockholder holds all right, title and interest in and
to the Shares such Stockholder purports to hold, free and clear of all liens and encumbrances, (B) the obligations of the Stockholder
in connection with the proposed Change in Control have been duly authorized, if applicable, (C) the documents to be entered into
by the Stockholder have been duly executed by the Stockholder and delivered to the acquirer and are enforceable against the Stockholder
in accordance with their respective terms, and (D) neither the execution and delivery of documents to be entered into in connection
with such proposed Change in Control, nor the performance of the Stockholder’s obligations thereunder, will cause a breach
or violation of the terms of any agreement, law or judgment, order or decree of any court or governmental agency;

 

(ii)         the
Stockholder shall not be liable for the inaccuracy of any representation or warranty made by any other Person in connection with
such proposed Change in Control, other than the Company (except to the extent that funds may be paid in proportion to the amount
of consideration to be received by such Stockholder out of an escrow established to cover breach of representations, warranties
and covenants of the Company as well as breach by any Stockholder of any of identical representations, warranties and covenants
provided by all Stockholders);

 

(iii)        the
liability for indemnification, if any, of such Stockholder in such proposed Change in Control and for the inaccuracy of any representations
and warranties made by the Company in connection with such proposed Change in Control, is several and not joint with any other
Person (except to the extent that funds may be paid out of an escrow established to cover breach of representations, warranties
and covenants of the Company as well as breach by any Stockholder of any of identical representations, warranties and covenants
provided by all Stockholders), and is pro rata in proportion to the amount of consideration paid to such Stockholder in connection
with such proposed Change in Control (in accordance with the provisions of the Certificate);

 

    	 	9	 

     

    

 

(iv)        the
Stockholder’s liability shall be limited to such Stockholder’s applicable share (determined based on the respective
proceeds payable to each Stockholder in connection with such proposed Change in Control in accordance with the provisions of the
Certificate) of a negotiated aggregate indemnification amount that applies equally to all Stockholders but that in no event exceeds
the amount of consideration otherwise payable to such Stockholder in connection with such proposed Change in Control, except with
respect to claims related to fraud, intentional misrepresentation or willful misconduct by such Stockholder, the liability for
which need not be limited as to such Stockholder;

 

(v)         upon
the consummation of such proposed Change in Control, (A) each holder of each class or series of the Company’s capital stock
will receive the same form of consideration for their shares of such class or series as is received by other holders in respect
of their shares of such same class or series of stock, (B) each holder of a series of Preferred Stock will receive the same amount
of consideration per share of such series of Preferred Stock as is received by other holders in respect of their shares of Preferred
Stock of such same series, (C) each holder of the Common Stock will receive the same amount of consideration per share of such
Common Stock as is received by other holders in respect of their shares of the Common Stock, and (D) the aggregate consideration
receivable by all holders of the Company Preferred Stock and Common Stock shall be allocated among the holders of the Company Preferred
Stock and Common Stock on the basis of the relative liquidation preferences, if any, set forth in the Certificate in connection
with a liquidation or a Change in Control, as applicable; and

 

(vi)        subject
to the foregoing subsection (v), requiring the same form of consideration to be available to the holders of any single class or
series of capital stock, if any holders of any capital stock of the Company are given an option as to the form and amount of consideration
to be received as a result of such proposed Change in Control, all holders of such capital stock will be given the same option.

 

4.8           Irrevocable
Proxy. Each Stockholder hereby
constitutes and appoints the Secretary and each Assistant Secretary of the Company, with full power of substitution, as the proxies
of the party with respect to the matters set forth herein, including without limitation, election of the Directors in accordance
with Section 4.4 and the drag-along provisions of Section 4.7, and hereby authorizes each of them to represent and
to vote, if and only if the party (a) fails
to vote or (b) attempts to vote (whether by proxy, in person
or by written consent), in a manner which is inconsistent with the terms of this Agreement, all of such party’s
Shares in accordance with such sections. The proxy granted pursuant to the immediately preceding sentence is given in consideration
of the agreements and covenants of the Company and the parties in connection with the transactions contemplated by this Agreement
and, as such, is coupled with an interest and shall be irrevocable unless and until this Agreement terminates or expires pursuant
to Section 5.5. Each Stockholder hereby revokes any and all previous proxies with respect to the Shares and shall not hereafter,
unless and until this Agreement terminates or expires pursuant to Section 5.5, purport to grant any other proxy or power
of attorney with respect to any of the Shares, deposit any of the Shares into a voting trust or enter into any agreement (other
than this Agreement), arrangement or understanding with any person, directly or indirectly, to vote, grant any proxy or give instructions
with respect to the voting of any of the Shares, in each case, with respect to any of the matters set forth herein.

 

    	 	10	 

     

    

 

4.9          Additional
Shares.

 

(a)          In
the event that after the Effective Date, the Company enters into an agreement with any Person to issue shares of capital stock
to such Person, following which such Person shall hold Shares, then the Company shall cause such Person, as a condition precedent
to entering into such agreement, to become a party to this Agreement by executing an Adoption Agreement in the form attached to
this Agreement as Exhibit 1 (the “Adoption Agreement”),
agreeing to be bound by and subject to the terms of this Agreement as a Stockholder and thereafter such person shall be deemed
a Stockholder for all purposes under this Agreement.

 

(b)          In
the event that subsequent to the Effective Date any shares or other securities are issued on, or in exchange for, any of a Stockholder’s
Shares by reason of any stock dividend, stock split, combination of shares, reclassification or the like, such shares or securities
shall be deemed to be Shares for purposes of this Agreement.

 

5.             MISCELLANEOUS.

 

5.1           Ownership.
Each Stockholder represents
and warrants to the other Stockholders and the Company that (a) such
Stockholder now owns the Stockholder’s Shares, free and clear
of liens or encumbrances, and has not, prior to or on the Effective Date, executed or delivered any proxy or entered into any other
voting agreement or similar arrangement other than one which has expired or terminated prior to the Effective Date, and (b) such
Stockholder has full power and capacity to execute, deliver and perform this Agreement, which has been duly executed and delivered
by, and evidences the valid and binding obligation of, such Stockholder enforceable in accordance with its terms.

 

5.2           Further
Action. If and whenever a Stockholder’s
Shares are sold, the Stockholder or the personal representative of the Stockholder shall do all things and execute and deliver
all documents and make all transfers, and cause any transferee of the Stockholder Shares to do all things and execute and deliver
all documents, as may be necessary to consummate such sale consistent with this Agreement.

 

5.3           Specific
Performance. The parties hereto
hereby declare that it is impossible to measure in money the damages which will accrue to a party hereto or to their heirs, personal
representatives, or assigns by reason of a failure to perform any of the obligations under this Agreement and agree that the terms
of this Agreement shall be specifically enforceable. If any party hereto or his heirs, personal representatives, or assigns institutes
any action or proceeding to specifically enforce the provisions hereof, any person against whom such action or proceeding is brought
hereby waives the claim or defense therein that such party or such personal representative has an adequate remedy at law, and such
person shall not offer in any such action or proceeding the claim or defense that such remedy at law exists.

 

5.4           Remedies
Cumulative. All remedies, either
under this Agreement or by law or otherwise afforded to any party, shall be cumulative and not alternative.

 

5.5           Termination.
Except as otherwise provided
in this Agreement, this Agreement shall continue in full force and effect from the Effective Date through the earliest of the following
dates, on which date it shall terminate in its entirety:

 

    	 	11	 

     

    

 

(a)          the
date of the closing of the Initial Offering;

 

(b)          the
date of the closing of a Change in Control; or

 

(c)          the
date upon which the parties hereto terminate this Agreement by written consent of the Company and the holders of at least a majority
of the outstanding shares of capital stock of the Company subject to this Agreement.

 

5.6           Governing
Law; Venue; Waiver of Jury Trial. This
Agreement shall be governed by and construed in accordance with the laws of the State of Delaware, without regard to its principles
of conflicts of laws. Each of the parties hereto irrevocably submits to the exclusive jurisdiction of the courts of the State of
Minnesota and any United States District Court in the State of Minnesota for the purpose of any suit, action, proceeding or judgment
relating to or arising out of this Agreement and the transactions contemplated hereby. 
Service of process in connection with any such suit, action or proceeding may be served on each party hereto anywhere in the world
by the same methods as are specified for the giving of notices under this Agreement. 
Each of the parties hereto irrevocably consents to the jurisdiction of any such court in any such suit, action or proceeding and
to the laying of venue in such court.  Each party hereto irrevocably
waives any objection to the laying of venue of any such suit, action or proceeding brought in such courts and irrevocably waives
any claim that any such suit, action or proceeding brought in any such court has been brought in an inconvenient forum. EACH OF
THE PARTIES HERETO WAIVES ANY RIGHT TO REQUEST A TRIAL BY JURY IN ANY LITIGATION WITH RESPECT TO THIS AGREEMENT AND REPRESENTS
THAT COUNSEL HAS BEEN CONSULTED SPECIFICALLY AS TO THIS WAIVER.

 

5.7           Successors
and Assigns. Except as otherwise
expressly provided herein, the provisions hereof shall inure to the benefit of, and be binding upon, the successors, assigns, heirs,
executors, and administrators of the parties hereto and shall inure to the benefit of and be enforceable by each person who shall
be a holder of Shares from time to time and become a party to this Agreement.

 

5.8           Transfers.
As a condition precedent to
the Company’s
recognizing any transferee or assignee of any Shares to any Person, such Person shall agree in writing to be subject to each of
the terms of this Agreement by executing and delivering an Adoption Agreement. Upon the execution and delivery of an Adoption
Agreement by any transferee, such transferee shall be deemed to be a party hereto as if such transferee were the transferor and
such transferee’s signature appeared on the signature pages
of this Agreement and shall be deemed to be a Stockholder. The Company shall not permit the transfer of the Shares subject to
this Agreement on its books or issue a new certificate representing any such Shares unless and until such transferee shall have
complied with the terms of Section 2.1. Each certificate representing the Shares subject to this Agreement if issued on
or after the Effective Date shall be endorsed by the Company with the legend set forth in Section 2.5.

 

5.9           Entire
Agreement. This Agreement,
the Exhibits and Schedules hereto and the other documents delivered pursuant thereto constitute the full and entire understanding
and agreement between the parties with regard to the subjects hereof and no party shall be liable or bound to any other in any
manner by any representations, warranties, covenants and agreements except as specifically set forth herein and therein.

 

    	 	12	 

     

    

 

5.10        Severability.
In the event one or more of
the provisions of this Agreement should, for any reason, be held to be invalid, illegal or unenforceable in any respect, such invalidity,
illegality, or unenforceability shall not affect any other provisions of this Agreement, and this Agreement shall be construed
as if such invalid, illegal or unenforceable provision had never been contained herein.

 

5.11        Amendment
and Waiver.

 

(a)          Except
as otherwise expressly provided herein, this Agreement may be amended or modified only upon the written consent of the Company
and the holders of at least a majority of the outstanding shares of capital stock of the Company subject to this Agreement. Any
such amendment or modification effected in accordance with this Section 5.11(a) shall be binding on all stockholders of
the Company, even if they do not execute such consent.

 

(b)          Any
party hereto may waive compliance with any agreements, covenants or conditions for the benefit of such party contained herein.
Any agreement on the part of a party hereto to any such waiver shall be valid only if set forth in an instrument in writing signed
on behalf of such party.

 

(c)          Except
as otherwise expressly provided, the obligations of the Company and the rights of the Stockholders under this Agreement may be
waived with respect to all stockholders of the Company (either generally or in a particular instance and either retroactively or
prospectively) only with the written consent of the Company and the holders of at least a majority of the outstanding shares of
capital stock of the Company subject to this Agreement. Any such waiver effected in accordance with this Section 5.11(c)
shall be binding on all stockholders of the Company, even if they do not execute such consent. Each Stockholder acknowledges that
by the operation of this Section 5.11(c), holders of at least a majority of the outstanding capital stock of the Company
subject to this Agreement will have the right and power to diminish or eliminate all rights of any Stockholder under this Agreement.

 

(d)          For
the purposes of determining the Stockholders entitled to vote or exercise any rights hereunder, the Company shall be entitled to
rely solely on the list of record holders of its stock as maintained by or on behalf of the Company.

 

5.12        Delays
or Omissions. It is agreed
that no delay or omission to exercise any right, power, or remedy accruing to any Stockholder, upon any breach, default or noncompliance
of the Company under this Agreement shall impair any such right, power, or remedy, nor shall it be construed to be a waiver of
any such breach, default or noncompliance, or any acquiescence therein, or of any similar breach, default or noncompliance thereafter
occurring. It is further agreed that any waiver, permit, consent, or approval of any kind or character on any Stockholder’s
part of any breach, default or noncompliance under the Agreement or any waiver on such Stockholder’s
part of any provisions or conditions of this Agreement must be in writing and shall be effective only to the extent specifically
set forth in such writing. All remedies, either under this Agreement, by law, or otherwise afforded to Stockholders, shall be cumulative
and not alternative.

 

    	 	13	 

     

    

 

5.13        Notices.
All notices required or permitted
hereunder shall be in writing and shall be deemed effectively given: (a) upon
personal delivery to the party to be notified; (b) when sent
by confirmed electronic mail or facsimile if sent during normal business hours of the recipient; if not, then on the next business
day; (c) five (5) days after having been sent by registered
or certified mail, return receipt requested, postage prepaid; or (d) one
(1) day after deposit with a nationally recognized overnight courier, specifying next day delivery, with written verification of
receipt. All communications shall be sent to the party to be notified at the address as set forth on the signature pages, Schedules
or Exhibits attached hereto, at the address on the Company’s
records for Stockholders, or at such other address as such party may designate by ten (10) days’
advance written notice to the other parties hereto.

 

5.14        Attorneys’
Fees. In the event that any
suit or action is instituted to enforce any provision in this Agreement, the prevailing party in such dispute shall be entitled
to recover from the losing party all fees, costs and expenses of enforcing any right of such prevailing party under or with respect
to this Agreement, including without limitation, such reasonable fees and expenses of attorneys and accountants, which shall include,
without limitation, all fees, costs and expenses of appeals.

 

5.15        Titles
and Subtitles. The titles of
the sections and subsections of this Agreement are for convenience of reference only and are not to be considered in construing
this Agreement.

 

5.16        Additional
Major Stockholders. Notwithstanding
anything to the contrary contained herein, if the Company shall issue Equity Securities in accordance with Section 3, any
purchaser of such Equity Securities that would qualify such purchaser as a Stockholder or Major Stockholder shall become a party
to this Agreement by executing and delivering an additional counterpart signature page to this Agreement or an Adoption Agreement
and shall be deemed a party hereunder and a “Stockholder”
and, as applicable, a “Major Stockholder”.

 

5.17        Aggregation
of Stock. All Shares held or
acquired by Affiliated entities or persons or persons or entities under common management or control shall be aggregated together
for the purpose of determining the availability of any rights under this Agreement.

 

5.18        Counterparts.
This Agreement may be executed
and delivered in any number of counterparts and by a separate instrument that references this Agreement for purposes of execution
and delivery hereof, each of which shall be an original, but all of which together shall constitute one instrument. This Agreement
may be executed and delivered by facsimile or other means of electronically imaging a signature.

 

SIGNATURES
ON FOLLOWING PAGES

 

    	 	14	 

     

    

 

IN WITNESS WHEREOF,
the parties hereto have executed this Stockholders Agreement as of the date
set forth in the first paragraph hereof.

 

	THE COMPANY:	 
	 	 
	NeuroOne, Inc.	 
	 	 	 
	By:	/s/ Dave Rosa	 
	Name:	Dave Rosa	 
	Title:	Chief Executive Officer	 

 

Signature
Page to Stockholders Agreement of

NeuroOne, Inc.

 

     

     

    

 

IN WITNESS WHEREOF,
the parties hereto have executed this Stockholders Agreement as of the date
set forth in the first paragraph hereof.

 

	THE STOCKHOLDERS:	 
	 	 
	/s/ Dave Rosa	 
	Dave Rosa	 

 

Signature
Page to Stockholders Agreement of

NeuroOne, Inc.

 

     

     

    

 

IN WITNESS WHEREOF,
the parties hereto have executed this Stockholders Agreement as of the date
set forth in the first paragraph hereof.

 

	THE STOCKHOLDERS:	 
	 	 
	/s/ Wade Fredrickson	 
	Wade Fredrickson	 

 

Signature
Page to Stockholders Agreement of

NeuroOne, Inc.

 

     

     

    

 

IN WITNESS WHEREOF,
the parties hereto have executed this Stockholders Agreement as of the date
set forth in the first paragraph hereof.

 

	THE STOCKHOLDERS:	 
	 	 
	/s/ Mark Christianson	 
	Mark Christianson 	 

 

Signature
Page to Stockholders Agreement of

NeuroOne, Inc.

 

     

     

    

 

IN WITNESS WHEREOF,
the parties hereto have executed this Stockholders Agreement as of the date
set forth in the first paragraph hereof.

 

	THE STOCKHOLDERS:	 
	 	 
	/s/ Time Geck	 
	Tim Geck 	 

 

Signature
Page to Stockholders Agreement of

NeuroOne, Inc.

 

     

     

    

 

IN WITNESS WHEREOF,
the parties hereto have executed this Stockholders Agreement as of the date
set forth in the first paragraph hereof.

 

	THE STOCKHOLDERS:	 
	 	 
	Mayo Foundation for	 
	Medical Education and Research	 
	 	 
	By: 	                               	 
	Name: 	 	 
	Title: 	 	 

 

Signature
Page to Stockholders Agreement of

NeuroOne, Inc.

 

     

     

    

 

IN WITNESS WHEREOF,
the parties hereto have executed this Stockholders Agreement as of the date
set forth in the first paragraph hereof.

 

	THE STOCKHOLDERS:	 
	 	 
	/s/ Steve Friswold	 
	Steve Friswold	 

 

Signature
Page to Stockholders Agreement of

NeuroOne, Inc.

 

     

     

    

 

IN WITNESS WHEREOF,
the parties hereto have executed this Stockholders Agreement as of the date
set forth in the first paragraph hereof.

 

	THE STOCKHOLDERS:	 
	 	 
	/s/ Sean Wambold	 
	Sean Wambold	 

 

Signature
Page to Stockholders Agreement of

NeuroOne, Inc.

 

     

     

    

 

IN WITNESS WHEREOF,
the parties hereto have executed this Stockholders Agreement as of the date
set forth in the first paragraph hereof.

 

	THE STOCKHOLDERS:	 
	 	 
	Jake Hertel	 
	Jake Hertel	 

 

Signature
Page to Stockholders Agreement of

NeuroOne, Inc.

 

     

     

    

 

IN WITNESS WHEREOF,
the parties hereto have executed this Stockholders Agreement as of the date
set forth in the first paragraph hereof.

 

	THE STOCKHOLDERS:	 
	 	 
	/s/ Brent Moen	 
	Brent Moen	 

 

Signature
Page to Stockholders Agreement of

NeuroOne, Inc.

 

     

     

    

 

Schedule
A

 

LIST OF STOCKHOLDERS

 

	Name	 	Address
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 

 

Schedule
A-1

 

     

     

    

 

Exhibit
1

 

ADOPTION AGREEMENT

 

THIS ADOPTION AGREEMENT
(the “Adoption Agreement”) is made as of _______________, 20__, by the undersigned (the “Stockholder”)
pursuant to the terms of that certain Stockholders Agreement dated effective as of October 20, 2016 (the “Stockholders
Agreement”), by and among NeuroOne, Inc., a Delaware corporation (the
“Company”), and its stockholders, as it may be amended or restated hereafter and from time to time. Capitalized
terms used but not defined in this Adoption Agreement shall have the respective meanings ascribed to such terms in the Stockholders
Agreement. By the execution of this Adoption Agreement, the Stockholder agrees as follows.

 

1.1           Acknowledgement.
The Stockholder acknowledges that the Stockholder is acquiring certain shares of the capital stock of the Company (the “Stock”)
[or options, warrants or other rights to purchase the Stock (the “Options”)], for one of the following
reasons (check the correct box):

 

		 ̈	as a transferee of Shares from a party in such party’s capacity as a “Stockholder”
bound by the Stockholders Agreement, and after such transfer, Stockholder shall be considered a “Stockholder” for all
purposes under the Stockholders Agreement.

 

		 ̈	as purchaser of shares of capital stock in the Company in accordance with Section 4.9(a) of the
Stockholders Agreement, in which case the Stockholder will be considered a “Stockholder” for all purposes under the
Stockholders Agreement.

 

1.2           Agreement.
The Stockholder hereby (a) agrees that the Stock [Options], and any other shares of capital stock or securities required by the
Stockholders Agreement to be bound thereby, shall be bound by and subject to the terms of the Stockholders Agreement, and (b) adopts
the Stockholders Agreement with the same force and effect as if the Stockholder were originally a party thereto.

 

1.3           Notice.
Any notice required or permitted by the Stockholders Agreement shall be given to the Stockholder at the address or facsimile number
listed below the Stockholder’s signature hereto.

 

	THE STOCKHOLDER:	 	 	ACCEPTED AND AGREED:
	 	 	 
	 	 	NeuroOne, Inc.
	By:	 	 	 	 	 
	Name:	          	 	 	 	 
	Title:	 	 	 	 	 
	Address:	 	 	 	By:	 
	 	 	 	Name:	 
	Facsimile Number:	 	 	Title:	 

 

Exhibit
1-1

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00272-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00272-of-00352.parquet"}]]